User profiles for D. Siegwart
Daniel SiegwartProfessor, University of Texas Southwestern Medical Center Verified email at utsouthwestern.edu Cited by 11849 |
The development of microgels/nanogels for drug delivery applications
JK Oh, R Drumright, DJ Siegwart… - Progress in polymer …, 2008 - Elsevier
… HA is a naturally occurring mucopolysaccharide composing of N-acetyl-d-glucosamine and
d-glucuronic acid, found in the extracellular tissue matrix of vertebrates. Dex is a bacterial-…
d-glucuronic acid, found in the extracellular tissue matrix of vertebrates. Dex is a bacterial-…
[HTML][HTML] Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs
SA Dilliard, DJ Siegwart - Nature Reviews Materials, 2023 - nature.com
Genetic drugs based on nucleic acid biomolecules are a rapidly emerging class of medicines
that directly reprogramme the central dogma of biology to prevent and treat disease. …
that directly reprogramme the central dogma of biology to prevent and treat disease. …
ATRP in the design of functional materials for biomedical applications
DJ Siegwart, JK Oh, K Matyjaszewski - Progress in polymer science, 2012 - Elsevier
Atom Transfer Radical Polymerization (ATRP) is an effective technique for the design and
preparation of multifunctional, nanostructured materials for a variety of applications in biology …
preparation of multifunctional, nanostructured materials for a variety of applications in biology …
Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
…, L Farbiak, LT Johnson, SA Dilliard, DJ Siegwart - Nature …, 2020 - nature.com
… d, Relative luciferase expression in each organ demonstrated that fractional expression
could be predictably tuned (0.1 mg kg −1 Luc mRNA, iv, 6 h). Data are shown as mean ± sem (n …
could be predictably tuned (0.1 mg kg −1 Luc mRNA, iv, 6 h). Data are shown as mean ± sem (n …
On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
…, Q Cheng, DJ Siegwart - Proceedings of the …, 2021 - National Acad Sciences
Lipid nanoparticles (LNPs) are a clinically mature technology for the delivery of genetic
medicines but have limited therapeutic applications due to liver accumulation. Recently, our …
medicines but have limited therapeutic applications due to liver accumulation. Recently, our …
[HTML][HTML] Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
… d H&E and Ki67 staining further confirmed progressive tumor formation. Higher tumor
proliferation biomarker Ki67 expression was detected in tumor lesions. Scale bar = 100 μm. …
proliferation biomarker Ki67 expression was detected in tumor lesions. Scale bar = 100 μm. …
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
…, AKR Lytton-Jean, DJ Siegwart… - Proceedings of the …, 2014 - National Acad Sciences
… (D) Microwave irradiation of epoxides and dipeptides dramatically reduced the reaction
time from 3 d to 5 h. Reactions between lysine–lysine and poly-l-lysine and aldehydes and …
time from 3 d to 5 h. Reactions between lysine–lysine and poly-l-lysine and aldehydes and …
Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy
… , Representative 3D construction of immunofluorescence (c) and 3D surface plot of
quantification (d) of collagen I and YAP in fixed tumour tissues after 30 d therapy of mice by weekly …
quantification (d) of collagen I and YAP in fixed tumour tissues after 30 d therapy of mice by weekly …
Non‐viral CRISPR/Cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co‐delivery of Cas9 mRNA and sgRNA
… D) Surveyor confirmed editing of the luciferase target at mRNA:sgRNA ratios of 3:1 or higher
… the Surveyor assay (Figure 4 D), while control ZNPs did not show any editing (Figure S21). …
… the Surveyor assay (Figure 4 D), while control ZNPs did not show any editing (Figure S21). …
Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing
… d, A list of 28 amines and 13 alkylated dioxaphospholane oxide molecules used for iPhos
… d, mRNA expression in spleen by iPhos with different alkyl chain length at phosphate group …
… d, mRNA expression in spleen by iPhos with different alkyl chain length at phosphate group …